IRCT20200428047228N2招募中3 期
Evaluation of the efficiency of hydroxychloroquine drug regimen in comparison with hydroxychloroquine + azithromycin in hospitalized patients with covid-19 in the intensive care unit
Quality Improvement of Intensive Care Research Center- Shahid Beheshti University0 个研究点目标入组 40 人开始时间: 待定最近更新:
适应症
试验速览
- 阶段
- 3 期
- 状态
- 招募中
- 发起方
- 入组人数
- 40
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- 16 years 至 100 years（—）
- 性别
- All
入选标准
- •Diagnosis of COVID-19 based on either ground glass appearance in chest CT scan or positive RT-PCR test for COVID-19
- •Requiring hospitalization on the basis of level of consciousness,blood pressure, kidney and liver failure
- •Patient's age between 16 and 100 years
- •Signed informed consent form
排除标准
- •Chronic liver and kidney failure
- •HIV patients
- •pregnancy and breast feeding
- •QT interval more than 500 milliseconds
研究者
相似试验
进行中（未招募）
不适用
Evaluation of the efficacy of hydroxychloroquine in decreasing immune activation in asymptomatic HIV-infected patients (HCQ-01) - Hydroxychloroquine studyHIV infectionMedDRA version: 9.1Level: LLTClassification code 10020161Term: HIV infectionEUCTR2007-005057-36-GBMedical Research Council
已完成
不适用
HCQ-01 Trial: evaluation of the efficacy of hydroxychloroquine in decreasing immune activation in asymptomatic human immunodeficiency virus (HIV) infected patientsISRCTN30019040Medical Research Council Clinical Trials Unit (MRC CTU) (UK)90
尚未招募
3 期
Efficacy of hydroxychloroquine in graves disease in addition to antithyroid drugs.CTRI/2023/07/054894IPQA laboratories
招募中
不适用
Evaluate the efficacy of hydroxychloroquine in the prevention of SARS-COV2 infection in high risk health care workersIRCT20200414047076N1Esfahan University of Medical Sciences160
进行中（未招募）
不适用
Efficacy of the treatment with hydroxychloroquine in non responders HIV-infected HAART-treated patients - NDHIV infection (immunological nonresponders).MedDRA version: 9.1Level: LLTClassification code 10008922EUCTR2009-012499-28-ITAZIENDA OSPEDALIERA L. SACCO (A.O. DI RILIEVO NAZIONALE)40